Active	Status	Sponsor type	Region	Phase	Filter
4 Active 0 Inactive 4 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

4 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Hayllar, Jeremy
TEMPO, NCT04014179: Enhancing Hepatitis C Testing and Treatment Among People Who Inject Drugs Attending Needle and Syringe Programs	Recruiting	N/A	2700	RoW	Xpert HCV Viral Load Fingerstick, Aptima HCV Quant DX Assay	Kirby Institute	Hepatitis C, Hepatitis C, Chronic	12/25	12/25
NCT05042544: The National Australian HCV Point-of-Care Testing Program	Recruiting	N/A	40000	RoW	Point-of-Care Testing	Kirby Institute, Flinders University	Hepatitis C	12/24	12/26
ETHOS II, NCT03685045: ETHOS ENGAGE: Enhancing Treatment of Hepatitis C in Opioid Substitution Settings	Recruiting	N/A	6000	RoW	Campaign days	Kirby Institute, National Health and Medical Research Council, Australia	Hepatitis C	01/25	01/25
Leader, Franklin John
TEMPO, NCT04014179: Enhancing Hepatitis C Testing and Treatment Among People Who Inject Drugs Attending Needle and Syringe Programs	Recruiting	N/A	2700	RoW	Xpert HCV Viral Load Fingerstick, Aptima HCV Quant DX Assay	Kirby Institute	Hepatitis C, Hepatitis C, Chronic	12/25	12/25